Raza A - Search Results

1

Myelodysplastic syndrome with pure red cell aplasia shows characteristic clinicopathological features and clonal T-cell expansion.

Wang SA, Yue G, Hutchinson L, Landry ML, Hasserjian RP, Hao S, Galili N, Raza A, Woda BA. Wang SA, et al. Among authors: raza a. Br J Haematol. 2007 Jul;138(2):271-5. doi: 10.1111/j.1365-2141.2007.06648.x. Epub 2007 Jun 3. Br J Haematol. 2007. PMID: 17542981 Free article. No abstract available.

2

Clinical implications of gene expression profiling in myelodysplastic syndromes: recognition of ribosomal and translational gene dysregulation and development of predictive assays.

Galili N, Raza A. Galili N, et al. Among authors: raza a. Best Pract Res Clin Haematol. 2009 Jun;22(2):223-37. doi: 10.1016/j.beha.2009.04.006. Best Pract Res Clin Haematol. 2009. PMID: 19698930

3

Prognosis in myelodysplastic syndromes: are the new classifications useful?

Galili N, Raza A. Galili N, et al. Among authors: raza a. Curr Hematol Malig Rep. 2008 Jan;3(1):19-22. doi: 10.1007/s11899-008-0004-z. Curr Hematol Malig Rep. 2008. PMID: 20425442

4

The biology and treatment of myelodysplastic syndromes.

Raza A, Galili N. Raza A, et al. Rinsho Ketsueki. 2013 Oct;54(10):1730-6. Rinsho Ketsueki. 2013. PMID: 24064823 Review. No abstract available.

5

Hypocellularity in myelodysplastic syndrome is an independent factor which predicts a favorable outcome.

Yue G, Hao S, Fadare O, Baker S, Pozdnyakova O, Galili N, Woda BA, Raza A, Wang SA. Yue G, et al. Among authors: raza a. Leuk Res. 2008 Apr;32(4):553-8. doi: 10.1016/j.leukres.2007.08.006. Epub 2007 Sep 20. Leuk Res. 2008. PMID: 17888511

6

Increased incidence of mitochondrial cytochrome c-oxidase gene mutations in patients with myelodysplastic syndromes.

Reddy PL, Shetty VT, Dutt D, York A, Dar S, Mundle SD, Allampallam K, Alvi S, Galili N, Saberwal GS, Anthwal S, Shaikh M, Suleman S, Kamal SY, Raza A. Reddy PL, et al. Among authors: raza a. Br J Haematol. 2002 Mar;116(3):564-75. doi: 10.1046/j.0007-1048.2001.03323.x. Br J Haematol. 2002. PMID: 11849212 Free article.

7

Excessive apoptosis, increased phagocytosis, nuclear inclusion bodies and cylindrical confronting cisternae in bone marrow biopsies of myelodysplastic syndrome patients.

Shetty V, Hussaini S, Alvi S, Joshi L, Shaher A, Dangerfield B, Nascimben F, Mundle S, Allampallam K, Reddy P, Galili N, Raza A. Shetty V, et al. Among authors: raza a. Br J Haematol. 2002 Mar;116(4):817-25. doi: 10.1046/j.0007-1048.2002.03366.x. Br J Haematol. 2002. PMID: 11886386 Free article.

8

Can molecular profiling of cytogenetic subgroups draw a roadmap for individualizing therapy in myelodysplastic syndromes?

Galili NB, Mehdi M, Mumtaz M, Miron P, Woda B, Al-Homsi S, Westervelt P, Raza A. Galili NB, et al. Among authors: raza a. Future Oncol. 2006 Jun;2(3):407-15. doi: 10.2217/14796694.2.3.407. Future Oncol. 2006. PMID: 16787120 Review.

9

Immunomodulatory drugs in myelodysplastic syndromes.

Galili N, Raza A. Galili N, et al. Among authors: raza a. Expert Opin Investig Drugs. 2006 Jul;15(7):805-13. doi: 10.1517/13543784.15.7.805. Expert Opin Investig Drugs. 2006. PMID: 16787143 Review.

10

Erythroid-predominant myelodysplastic syndromes: enumeration of blasts from nonerythroid rather than total marrow cells provides superior risk stratification.

Wang SA, Tang G, Fadare O, Hao S, Raza A, Woda BA, Hasserjian RP. Wang SA, et al. Among authors: raza a. Mod Pathol. 2008 Nov;21(11):1394-402. doi: 10.1038/modpathol.2008.142. Epub 2008 Sep 12. Mod Pathol. 2008. PMID: 18839018 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,794 results

Search Page

Filters